Welcome to the e-CCO Library!

P412: Evolution of patients with ulcerative colitis who withdraw the maintenance treatment with mesalazine
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Algaba*, I. Guerra, D. Bonillo, M. Hernández, A. Granja, P. Bernal, F. Berrmejo

Created: Friday, 22 February 2019, 9:49 AM
P412: The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Orlando A.1, Macaluso F.S.*1, Fries W.2, Privitera A.C.3, Cappello M.4, Siringo S.5, Inserra G.6, Magnano A.7, Di Mitri R.8, Belluardo N.9, Scarpulla G.10, Magrì G.11, Trovatello N.12, Carroccio A.13, Genova S.14, Calandruccio G.15, Vassallo R.16, Romano C.17, Pellegrino S.17, Citrano M.18, Accomando S.19, Ventimiglia M.1, Renna S.1, Orlando R.1, Rizzuto G.1, Vinci E.1, Cottone M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P412: Time trend in clinicopathological features and prognosis of Ulcerative Colitis associated neoplasia: A nationwide cohort in Japan
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Komatsu, K.(1)*;Shinagawa, T.(1);Noguchi, T.(1);Uchino, M.(2);Ikeuchi, H.(2);Okabayashi, K.(3);Tanaka, S.(4);Futami, K.(5);Itabashi, M.(6);Watanabe, K.(7);Nagahara, H.(8);Okita, Y.(9);Shimada, Y.(10);Mizuuchi, Y.(11);Okamoto, K.(12);Yamada, K.(13);Sato, Y.(14);Mizushima, T.(15);Kimura, H.(16);Takahashi, K.(17);Hida, K.(18);Kinugasa, Y.(19);Ishida, F.(20);Okuda, J.(21);Daito, K.(22);Yamamoto, T.(23);Yamamoto, S.(24);Koyama, F.(25);Hanai, T.(26);Komori, K.(27);Shida, D.(28);Arakaki, J.(29);Akagi, Y.(30);Yamaguchi, S.(31);Ueno, H.(32);Matsuda, K.(33);Ajioka, Y.(34);Sugihara, K.(35);Ishihara, S.(1);
Created: Friday, 14 July 2023, 11:05 AM
P412: White cell count (WCC) and mean corpuscular volume (MCV) as surrogate markers for thiopurine monitoring in inflammatory bowel disease (IBD) treatment: A single-centre experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Christopher*, K. Altamimi, N. Campbell, R. Rynne-Lyons, A. Alakkari, A. O'Connor, D. McNamara, N. Breslin, B. Ryan

Created: Thursday, 21 February 2019, 9:14 AM
P413 General impressions about nutrition in patients with inflammatory bowel disease using a nutritional survey
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.A. Ruiz-Ramirez1, C. Suarez1, J. Poza1, E. Martin-Arranz1, J.L. Rueda-Garcia1, M. Sanchez-Azofra1, M. Cuadros1, P. Mayor1, L. Garcia-Ramirez2, M.D. Martin-Arranz1

Created: Thursday, 30 January 2020, 10:12 AM
P413: A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. S. Dulai*1, A. Amiot2, L. Peyrin-Biroulet3, S. Singh1, M. Serrero4, V. Jairath5, J. Filippi6, B. Pariente7, E. V. Loftus Jr8, X. Roblin9, S. Kane8, A. Buisson10, C. A. Siegel11, Y. Bouhnik12, W. J. Sandborn1, K. Lasch13, M. Rosario13, B. G. Feagan5, D. Bojic14, C. Trang-Poisson15, B. Shen16, R. Altwegg17, B. E. Sands18, J-F. Colombel18, F. Carbonnel19, M. Bohm20, D. Hudesman21, A. Bourrier22, D. Lukin23, GETAID OBSERV-IBD and VICTORY Cohorts Collaboration1

Created: Friday, 22 February 2019, 9:41 AM
P413: Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE)
Year: 2022
Source: ECCO'22
Authors: Tran, A.P.(1,2);Tassone, D.(3,4);Nossent, J.C.(2,5);Ding, N.S.(3,4);
Created: Friday, 11 February 2022, 3:52 PM
P413: Characteristics of the stricture, not the ongoing treatment, influence the outcome of endoscopic dilatation in recurrent Crohn`s disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Ladrón Abia, P.(1); Alonso, N.(2);Beltrán, B.(1);Minguez, A.(1);Sáez-González, E.(1);Pons-Beltrán, V.(2);Nos, P.(1);Iborra, M.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P413: Endoscopic balloon dilatation of Crohn’s strictures is safe and effective in selected cases
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Asairinachan*, V. An, E. Daniel, M. Johnston, J. Keck, P. Salama, R. Woods

Created: Friday, 22 February 2019, 9:49 AM
P413: Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Heerasing N.*1, Thompson B.1, Hendy P.1, Heap G.1,2, Walker G.1,2, Bethune R.1, Calvert C.1, Kennedy N.1,2, Ahmad T.1,2, Goodhand J.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P413: Relative frequency of relapses in patients with ulcerative colitis and Crohn's disease treated with mesenchymal stromal cells: Five-years of follow-up
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Fadeeva1*, O. Knyazev1, A. Kagramanova1, A. Babayan1, A. Lishchinskaya1, I. Ruchkina1, A. Konoplyannikov2, A. Parfenov1

Created: Thursday, 21 February 2019, 9:14 AM
P413: Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pudipeddi, A.(1)*;Paramsothy, S.(1);Kariyawasam, V.(2);Paramsothy, R.(2);Ghaly, S.(3);Haifer, C.(3);An, Y.K.(4);Begun, J.(4);Connor, S.(5);Corte, C.(6);Ward, M.(7);De Cruz, P.(8);Fung, C.(9);Redmond, D.(1);Leong, R.W.(1);
Created: Friday, 14 July 2023, 11:05 AM
P414 Risk factors for the development of anti-drug antibodies to infliximab and adalimumab in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Khoo1, A. Lord2, K. Hanigan1, A. Croft1, G. Radford-Smith1,2

Created: Thursday, 30 January 2020, 10:12 AM
P414: Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naïve patients with Crohn´s disease with propensity score adjustment: two-year maintenance phase results from the prospective VEDO-IBD study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bokemeyer, B.(1,2,3)*;Plachta-Danielzik, S.(3);Efken, P.(4);Mohl, W.(5);Hoffstadt, M.(6);Krause, T.(7);Schweitzer, A.(8);Schnoy, E.(9);Atreya, R.(10);Teich, N.(11);Trentmann, L.(12);Ehehalt, R.(13);Franzenburg, S.(3);Hartmann, P.(4);di Giuseppe, R.(3);Schreiber, S.(2,3);
Created: Friday, 14 July 2023, 11:05 AM
P414: Loss of response to anti-TNF in inflammatory bowel disease in a Portuguese centre
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Sousa*, A.P. Silva, A. Rodrigues, J. Rodrigues, J. Silva, C. Gomes, L. Proença, J. Carvalho

Created: Thursday, 21 February 2019, 9:14 AM
P414: Obesity is associated with a higher risk of immunogenicity to adalimumab, but not to infliximab in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Mahmoud, R.(1);Schultheiss, J.(1);Louwers, J.(1);van der Kaaij, M.(1);van Hellemondt, B.(1);Mahmmod, N.(2);van Boeckel, P.(2);Jharap, B.(3);Fidder, H.(1);Oldenburg, B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P414: Stoma in patiens with IBD: friend or foe? -\tEffect of stoma on course of disease, psychological well-being and working capacity
Year: 2022
Source: ECCO'22
Authors: Bianchi, R.(1);Von Känel, R.(2);Roth, R.(3);Schreiner, P.(1);Rossel, J.B.(4);Barry, M.P.(4);Dora, B.(1);Kloth, P.(1);Juillerat, P.(5);Greuter, T.(6);Misselwitz, B.(5);Schoepfer, A.(6);Scharl, M.(1);Rogler, G.(1);Biedermann, L.(1);
Created: Friday, 11 February 2022, 3:52 PM
P414: Usefulness of ultrasonography in the assessment of postoperative recurrence of Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Murakami*1, T. Kanemura1, A. Haga1, R. Kubota1, K. Yaguchi1, M. Nishio1, S. Tsuda1, T. Ogashiwa1, Y. Kogure1, K. Kasahara1, K. Hirai2, Y. Fukuno2, M. Jin2, A. Hanzawa2, H. Yonezawa2, K. Sakamaki3, K. Numata4, H. Kimura1, R. Kunisaki1

Created: Friday, 22 February 2019, 9:49 AM
P414: Ustekinumab endoscopic response at Week 16 is associated with early normalisation of faecal calprotectin after induction
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. W. M. Pauwels*1, A. C. de Vries1, J. C. Goet1, N. S. Erler2, C. J. van der Woude1

Created: Friday, 22 February 2019, 9:41 AM
P414: Vedolizumab in Pediatric inflammatory bowel diseases: a retrospective multi-center experience from the paediatric IBD Porto group of ESPGHAN
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ledder O.*1, de Meij T.2, Martín de Carpi J.3, Richmond L.4, Cohen S.5, Bronsky J.6, Shaoul R.7, Levine A.8, Escher J.9, deRidder L.9, Assa A.10, Ruemmele F.11, Shah N.12, Wolters V.13, Rodrigues A.14, Uhlig H.14, Urlep D.15, Posovsky C.16, Kolho K.17, Turner D.1

Created: Wednesday, 20 February 2019, 10:36 AM